Diego de Miguel-Perez
University of Maryland, Baltimore
H-index: 17
North America-United States
Top articles of Diego de Miguel-Perez
Engineered EVs for cancer drug delivery and therapeutics
2024/4/23
Diego De Miguel-Perez
H-Index: 10
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC
Journal of Experimental & Clinical Cancer Research
2024/3/15
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
Translational Oncology
2024/3/1
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma
European Journal of Cancer
2024/1/1
Diego De Miguel-Perez
H-Index: 10
Umberto Malapelle
H-Index: 28
Pasquale Pisapia
H-Index: 17
Alessandro Russo
H-Index: 24
Circulating epithelial cell as viral infection and tissue origin marker in patients with severe COVID-19
The Journal of Liquid Biopsy
2023/12/1
Diego De Miguel-Perez
H-Index: 10
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
Biomarker Research
2023/11/15
Extracellular vesicles as mediators of resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer preclinical models
The Journal of Liquid Biopsy
2023/11/1
Early Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization
The Journal of Liquid Biopsy
2023/11/1
Extracellular Vesicles Carry SARS-COV-2 Proteins Associated With Lower Antibody Production, Cardiovascular Complications, and Worse Outcomes in Patients With Severe COVID-19
The Journal of Liquid Biopsy
2023/11/1
P1. 21-06 Extracellular Vesicles and Radiomics Predict Durable Response to Immune-Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer
Journal of Thoracic Oncology
2023/11/1
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation
Clinical Lung Cancer
2023/11/1
Alessandro Russo
H-Index: 24
Diego De Miguel-Perez
H-Index: 10
Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer
Vaccines
2023/10/19
Diego De Miguel-Perez
H-Index: 10
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC
Lung Cancer
2023/9/1
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an …
Targeted Oncology
2023/5
Predictive capability of PD-L1 protein expression for patients with advanced NSCLC: Any differences based on histology?
2023/4/25
Diego De Miguel-Perez
H-Index: 10
PD. 01.03 Genomic Landscape of Primary-Resistance to Osimertinib among Hispanic Patients With EGFR-Mutant Non-Small-Cell Lung Cancer: Results of an Observational Longitudinal …
Journal of Thoracic Oncology
2023/3/1
Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer
Cancer
2023/2/15
Microfluidic systems in extracellular vesicles single analysis. A systematic review
2023/2/1
Matias Regiart
H-Index: 10
Diego De Miguel-Perez
H-Index: 10
EP16. 03-002 Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)
Journal of Thoracic Oncology
2022/9/1
P2. 13-01 Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC
Journal of Thoracic Oncology
2022/9/1
